Erschienen in:
26.02.2022 | Letter to the Editor
Pharmacologic Cardioversion of Paroxysmal Atrial Fibrillation in the Emergency Department in the Novel Anticoagulants’ Era
verfasst von:
Dimitris Tsiachris, Ioannis Doundoulakis, Konstantinos Tsioufis
Erschienen in:
Cardiovascular Drugs and Therapy
|
Ausgabe 6/2022
Einloggen, um Zugang zu erhalten
Excerpt
We read with great interest the reassessment of confidence of our network meta-analysis, which compared antiarrhythmic drugs for cardioversion of atrial fibrillation (AF), performed by deSouza et al. [
1,
2]. We acknowledge that they undertook a laborious task in re-analyzing our published results based on the crucial choice of duration of AF before pharmacologic cardioversion. …